Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other patient characteristics.This observational ART cohort study was based in Cape Town, South Africa. Deaths from all causes were ascertained among patients receiving ART for up to 8 years. TB diagnoses and 4-monthly CD4 cell counts were recorded. Mortality rates were calculated and Poisson regression models were used to calculate incidence rate ratios (IRR) and identify risk factors for mortality. Of 1544 patients starting ART, 464 patients had prevalent TB at ba...
Abstract Background Tuberculosis (TB) disease affects...
INTRODUCTION : South Africa is among countries with the highest burden of drug resistant tuberculosi...
OBJECTIVE: To investigate mortality rates and risk factors for death among smear-negative tuberculos...
Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes i...
BACKGROUND: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) ...
BACKGROUND: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) ...
There is high mortality among newly diagnosed Tuberculosis (TB) patients in Zululand Health District...
BackgroundIdentifying those at increased risk of death during TB treatment is a priority in resource...
Background. In 2013, the tuberculosis (TB) mortality rate was highest in southern Zimbabwe at 16%. W...
INTRODUCTION:South Africa is among countries with the highest burden of drug resistant tuberculosis ...
OBJECTIVE: Nine out of ten tuberculosis deaths occur in tuberculosis-burdened countries, particularl...
This cohort study utilized data from a large HIV treatment program in western Kenya to describe the ...
BACKGROUND:: Tuberculosis-HIV (TB-HIV) co-infection remains an important cause of mortality in antir...
This cohort study utilized data from a large HIV treatment program in western Kenya to describe the ...
<div><h3>Objective</h3><p>This cohort study utilized data from a large HIV treatment program in west...
Abstract Background Tuberculosis (TB) disease affects...
INTRODUCTION : South Africa is among countries with the highest burden of drug resistant tuberculosi...
OBJECTIVE: To investigate mortality rates and risk factors for death among smear-negative tuberculos...
Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes i...
BACKGROUND: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) ...
BACKGROUND: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) ...
There is high mortality among newly diagnosed Tuberculosis (TB) patients in Zululand Health District...
BackgroundIdentifying those at increased risk of death during TB treatment is a priority in resource...
Background. In 2013, the tuberculosis (TB) mortality rate was highest in southern Zimbabwe at 16%. W...
INTRODUCTION:South Africa is among countries with the highest burden of drug resistant tuberculosis ...
OBJECTIVE: Nine out of ten tuberculosis deaths occur in tuberculosis-burdened countries, particularl...
This cohort study utilized data from a large HIV treatment program in western Kenya to describe the ...
BACKGROUND:: Tuberculosis-HIV (TB-HIV) co-infection remains an important cause of mortality in antir...
This cohort study utilized data from a large HIV treatment program in western Kenya to describe the ...
<div><h3>Objective</h3><p>This cohort study utilized data from a large HIV treatment program in west...
Abstract Background Tuberculosis (TB) disease affects...
INTRODUCTION : South Africa is among countries with the highest burden of drug resistant tuberculosi...
OBJECTIVE: To investigate mortality rates and risk factors for death among smear-negative tuberculos...